ReviewFluids and barriers of the CNS2026
The meninges as a neuroimmune interface: structure, barriers and roles in CNS disease.
Review in Fluids and barriers of the CNS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Impact of blood contamination on hydrophilic metabolomics in human meningioma tissue.Analytical and bioanalytical chemistry · 2026Article
- The Epidermal Growth Factor Receptor (EGFR) as a means of neuro-immune cross-conversation.Journal of neuroinflammation · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The meninges form a highly specialized barrier and immune interface that protects the central nervous system (CNS), regulates cerebrospinal fluid (CSF) dynamics, and coordinates communication between the CNS and the periphery. Each layer—dura mater, arachnoid mater and pia mater—possesses distinct structural, vascular and immunological features that collectively shape CNS homeostasis. A broad range of anatomical and molecular studies has revealed that meningeal compartments are far more heterogeneous and functionally complex than traditionally recognized, particularly with respect to their barrier architecture and immune interactions. In this review, we summarize current knowledge of meningeal structure and function, with a focus on barrier properties and immune-cell trafficking. We further discuss how meningeal dysfunction contributes to pathology in bacterial meningitis, multiple sclerosis and Alzheimer’s disease. Emerging evidence highlights the meninges as an active neuroimmune organ rather than a passive covering, critically influencing inflammation, solute clearance and disease progression. Understanding these mechanisms may open new therapeutic avenues targeting meningeal pathways across neurological disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.